| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairperson &CEO | Director
2 companies
Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 99 sells.
Estimated insider holdings value: $23.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 7,200 | $274.16 | $1,973,943.43 | -37.7% | +27.1% | +12.7% | |
| May 22, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 3,600 | $277.20 | $997,918.38 | -30.1% | +25.5% | +11.7% | |
| May 21, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 7,200 | $274.97 | $1,979,771.89 | -45.8% | +26.7% | +12.5% | |
| May 17, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 7,200 | $272.82 | $1,964,298.92 | -37.7% | +17.8% | +11.3% | |
| May 15, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 7,200 | $270.35 | $1,946,521.95 | -29.4% | +18.7% | +11.5% | |
| May 13, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 7,200 | $265.49 | $1,911,532.11 | -46.8% | +26.3% | +16.5% | |
| May 9, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 7,200 | $263.67 | $1,898,392.88 | -31.5% | +21.1% | +13.3% | |
| May 7, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 3,600 | $263.82 | $949,737.25 | -32.1% | +22.3% | +15.3% | |
| May 6, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 7,200 | $259.89 | $1,871,233.28 | -25.8% | +25.0% | +13.2% | |
| May 2, 2024 | UTHR United Therapeutics Corp | Chairperson &CEO | Sale+OE | 7,200 | $254.15 | $1,829,903.18 | -16.3% | +21.4% | +14.1% |